Hydrochlorothiazide 25 mg Tablets — Generic For Microzide — Unichem

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Hydrochlorothiazide Tablets, USP are a diuretic and antihypertensive medicine. The label says they are used as adjunctive therapy for edema associated with congestive heart failure, hepatic cirrhosis, corticosteroid and estrogen therapy, and for edema due to certain kidney problems.

The tablets are also indicated for the management of hypertension, either alone or to help other antihypertensive medicines work better in more severe forms of high blood pressure.

The label warns that hydrochlorothiazide can affect fluid and electrolyte balance. It also notes important cautions and possible adverse reactions, including dizziness, low blood pressure, electrolyte imbalance, and sensitivity reactions.

The product is supplied as light orange tablets in 12.5 mg, 25 mg, and 50 mg strengths.

Storage Information

Dispense in a well-closed container as defined in the USP. Store at 20° to 25° C (68° to 77° F) [see USP Controlled Room Temperature].

Key Counseling Points

• Take this medicine only as directed on the label or by the prescriber.
• Hydrochlorothiazide is a diuretic and antihypertensive medicine.
• It may be used for edema and for management of hypertension.
• This medicine can cause fluid and electrolyte imbalance.
• Report symptoms listed on the label such as dryness of mouth, thirst, weakness, lethargy, drowsiness, confusion, muscle cramps, nausea, vomiting, or dizziness.
• The label notes that low potassium may occur and may be more likely with brisk diuresis or prolonged therapy.
• Tell a healthcare professional about other medicines, especially lithium, antidiabetic drugs, other antihypertensive drugs, corticosteroids, ACTH, or non-steroidal anti-inflammatory drugs.
• The label says patients taking hydrochlorothiazide should protect skin from the sun and undergo regular skin cancer screening.
• Seek prompt medical attention for decreased vision or eye pain, which the label associates with acute myopia and acute angle-closure glaucoma.
• If adverse reactions are moderate or severe, the label says dosage should be reduced or therapy withdrawn.

Helpful Patient Education

Hydrochlorothiazide Tablets, USP are a diuretic and antihypertensive medicine available in 12.5 mg, 25 mg, and 50 mg strengths. According to the DailyMed label, they are indicated for edema associated with congestive heart failure, hepatic cirrhosis, corticosteroid and estrogen therapy, and for edema related to certain renal conditions.

The label also states that hydrochlorothiazide is used in the management of hypertension, either alone or with other antihypertensive medicines. Educational labeling information includes cautions about electrolyte imbalance, interactions with several medicines, and the need for sun protection and regular skin cancer screening.

Medication Summary last generated: 2026-07-18 02:52:22